Merck KGaA
Merck KGaA
Website
HQ Country
Germany
Profile
Merck KGaA of Darmstadt, Germany, is a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors. Its subsidiaries in Canada and the United States operate under the umbrella brand EMD. Around 39,000 employees work in 66 countries to improve the quality of life for patients, to further the success of customers and to help meet global challenges. The company generated total revenues of € 11.1 billion in 2013 with its four divisions: Biopharmaceuticals, Consumer Health, Performance Materials and Life Science Tools. Merck KGaA of Darmstadt, Germany is the world's oldest pharmaceutical and chemical company - since 1668, the name has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day.
Filtered by:
Merck KGaA
Company
Topic
Show
2023
21 Aug 2023
White Biotechnology 2024-2034
IDTechEx Report: Sona Dadhania
14 Aug 2023
Displays for Virtual, Augmented and Mixed Reality 2024-2034: Forecasts, Technologies, Markets
IDTechEx Report: Sam Dale and Dr Xiaoxi He
2 Aug 2023
Quantum Dot Materials and Technologies 2024-2034: Trends, Markets, Applications
IDTechEx Report: Dr Xiaoxi He
16 Mar 2023
RFID Forecasts, Players and Opportunities 2023-2033
IDTechEx Report: Dr Yu-Han Chang and Raghu Das
2022
13 Dec 2022
Cultured Meat 2023-2043
IDTechEx Report:
9 Nov 2022
Materials Informatics 2023-2033
IDTechEx Report: Sam Dale
31 Aug 2022
DNA Sequencing 2023-2033: Technologies, Markets, and Forecasts
IDTechEx Report:
22 Aug 2022
Thin Film & Flexible Photovoltaics 2023-2033
IDTechEx Report:
13 Jul 2022
Graphene Market & 2D Materials Assessment 2023-2033
IDTechEx Report: Dr Conor O'Brien
29 Apr 2022
ASCA and Epishine Sign Their First Licensing Agreement for Printed OPV
Epishine is partnering with ASCA to strengthen and further develop the world-wide OPV market. ASCA recently acquired the most relevant intellectual property portfolio on printed OPV and the companies have signed a licensing agreement to share it beginning of April. The contract will enable the Swedish-based manufacturer Epishine to further improve its organic indoor light energy harvesting solar modules.
1 Apr 2022
Diabetes Management Technologies 2022-2032: Markets, Players, and Forecasts
IDTechEx Report:
29 Mar 2022
Biosensors for Point-of-Care Diagnostics 2022-2032: Technology, Opportunities, Players and Forecasts
IDTechEx Report:
2021
9 Nov 2021
Electroninks
Electroninks is a US-based company that develops and supplies particle-free inks for applications such as EMI shielding, PCB prototyping and textiles. IDTechEx caught up with CEO Brett Walker to find out more about the latest developments, including a $1.5m phase II Small Business Innovation Research (SBIR) contract to develop advanced manufacturing hardware and particle-free conductive inks for printed circuit boards from the Air Force Rapid Sustainment Office (RSO).
9 Sep 2021
Printed and Flexible Sensors 2022-2032: Technologies, Players, Markets
IDTechEx Report:
28 Jul 2021
Wiliot Secures $200 Million Investment Round Led by SoftBank Vision
For decades, there has remained a massive gap as trillions of products travel billions of miles without any data being available as to their status, whereabouts, or situation. Lacking this information, global supply chains have been profoundly, and vulnerably, in the dark. Recognizing this, many leaders in consumer-packaged goods, pharmaceuticals, furniture, and apparel have been working with Wiliot to add their sensing capabilities, intelligence and connectivity.27 Jul 2021
Wiliot
Wiliot is developing low-cost, energy-harvesting sensors that enable items to be tracked throughout the supply chain. On July 27 2021 it announced that it had received an investment of $200m from Softbank.
4 Jun 2021
AI in Drug Discovery 2021: Players, Technologies, and Applications
IDTechEx Report: Dr Nadia Tsao
12 Apr 2021
Micro-LED Displays 2021-2031: Technology, Commercialization, Opportunity, Market and Players
IDTechEx Report: Dr Xiaoxi He
24 Mar 2021
Merck KGaA (Cultured Meat)
Merck
Included are:
7 Jan 2021
Merck Today Announced the Acquisition of AmpTec
Merck acquires AmpTec to expand mRNA capabilities for vaccines, treatments and diagnostics. Adds to Merck's lipid manufacturing expertise, providing an integrated offering across mRNA value chain
